MA39153A1 - New heterocyclic compounds - Google Patents
New heterocyclic compoundsInfo
- Publication number
- MA39153A1 MA39153A1 MA39153A MA39153A MA39153A1 MA 39153 A1 MA39153 A1 MA 39153A1 MA 39153 A MA39153 A MA 39153A MA 39153 A MA39153 A MA 39153A MA 39153 A1 MA39153 A1 MA 39153A1
- Authority
- MA
- Morocco
- Prior art keywords
- heterocyclic compounds
- compounds
- new heterocyclic
- pharmaceutically acceptable
- relates
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés hétérocycliques de formule générale (i), leurs sels pharmaceutiquement acceptables, solvates pharmaceutiquement acceptables, énantiomères, diastéréoisomères, et polymorphes. L'invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques contenant ces composés, et leur utilisation en tant qu'inhibiteurs sélectifs de la tyrosine kinase de bruton (btk).(i)The present invention relates to heterocyclic compounds of general formula (i), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereoisomers, and polymorphs. The invention also relates to processes for the preparation of these compounds, pharmaceutical compositions containing these compounds, and their use as selective inhibitors of broncine tyrosine kinase (btk).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2271MU2014 | 2014-07-11 | ||
| PCT/IN2015/000063 WO2015132799A2 (en) | 2014-02-03 | 2015-02-02 | Novel heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39153A1 true MA39153A1 (en) | 2018-03-30 |
Family
ID=62203552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39153A MA39153A1 (en) | 2014-07-11 | 2015-02-02 | New heterocyclic compounds |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA39153A1 (en) |
-
2015
- 2015-02-02 MA MA39153A patent/MA39153A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501440A1 (en) | Novel heterocyclic compounds | |
| MA37405A1 (en) | Heterocyclyl compounds | |
| MA40225A (en) | SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS | |
| MX2021013075A (en) | OXYSTEROLS AND METHODS OF USE THEREOF. | |
| MA42230B1 (en) | Bicyclic derivatives, process for their preparation, and pharmaceutical compositions containing them | |
| EA201650031A1 (en) | DERIVATIVES PYRROLIDIN-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION AS IDO1 INHIBITORS | |
| EA201691428A1 (en) | BICYCLIC HETEROCYCLIC DERIVATIVES AS IRAK4 INHIBITORS | |
| TN2016000188A1 (en) | 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS | |
| EA201890086A1 (en) | 1,4-substituted derivatives of piperidine | |
| MA42231B1 (en) | New hydroxy acid derivatives, process for their preparation, and pharmaceutical compositions containing them | |
| EA202090052A1 (en) | IMIDAZOLE-CONTAINING ALK2 KINASE INHIBITORS | |
| MA40123A1 (en) | Pyrimidines used as factor xia inhibitors | |
| EA201691803A1 (en) | HUMAN PLASMA KALLIKREIN INHIBITORS | |
| MA38175B1 (en) | Lactams fused to an aryl and heteroaryl | |
| MA45222A (en) | NEW PIPERIDINYL DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA38138A1 (en) | New derivatives of quinolone | |
| MX2016016516A (en) | Phosphatidylinositol 3-kinase inhibitors. | |
| MA38287A1 (en) | New aminopyrazine derivatives for the treatment or prevention of cancer | |
| MX382122B (en) | OXYSTEROLS AND METHODS OF USING THEM. | |
| EA201492170A1 (en) | NEW CYPRIDE N-PYRIDINYLAMIDES SUBSTITUTED AS A KINAZ INHIBITOR | |
| MX2016016530A (en) | Phosphatidylinositol 3-kinase inhibitors. | |
| PE20170946A1 (en) | 2-AMINO-6- (DIFLUOROMETIL) - 5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS | |
| MX394108B (en) | N-SUBSTITUTED INDOL DERIVATIVES. | |
| JOP20190233A1 (en) | Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase | |
| EA201692557A1 (en) | CINOLYSINUM DERIVATIVES AS PI3K INHIBITORS |